Laddar...
HER-2/neu overexpression in breast cancer
Background: In breast carcinoma, amplification &/or over-expression of HER-2/neu has been associated with a group of unfavorable prognostic factors. The Food & Drug Administration Agency approved Trastuzumab (Herceptin) for the therapy of metastatic breast cancer but only in patients with am...
Sparad:
| Huvudupphovsmän: | , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Faculty of Medicine University of Baghdad
2010-10-01
|
| Serie: | مجلة كلية الطب |
| Ämnen: | |
| Länkar: | http://iqjmc.uobaghdad.edu.iq/index.php/19JFacMedBaghdad36/article/view/977 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|